Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9W70
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,763
Award facts
- Contract value 100% obligated
- $9,762.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,762.73 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalation powder, a combination respiratory medication used to treat chronic obstructive pulmonary disease. The contract, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a firm fixed-price purchase under a non-competed delivery order structure. The awardee, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor to federal healthcare systems, including military treatment facilities and veteran healthcare programs. This delivery order is a child contract executed under AmerisourceBergen's parent company, Cencora, Inc.
This delivery order leverages Cencora's comprehensive Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The parent IDC provides a flexible vehicle for supplying pharmaceutical products and medical commodities globally to support military healthcare operations. As a non-set-aside competitive award, this transaction demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements through open competition, consistent with its extensive portfolio of pharmaceutical delivery orders ranging across multiple therapeutic domains in support of Department of Defense healthcare missions.
Quick answers
Who was awarded contract SPE2DR26F9W70?
SPE2DR26F9W70 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9W70 worth?
The government has obligated $9,763 on SPE2DR26F9W70.
Is contract SPE2DR26F9W70 an order under another contract?
Yes. SPE2DR26F9W70 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W70 competed?
The extent of competition for SPE2DR26F9W70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award